Adiponectin in relation to malignancies: a review of existing basic research and clinical evidence.

Adiponectin, an adipocyte-secreted hormone that plays an important role in diabetes and cardiovascular disease, may also be of importance in the development and progression of several malignancies. Circulating adiponectin concentrations, which are determined mainly by genetic factors, nutrition, and adiposity, are lower in patients with breast, endometrial, prostate, and colon cancer. It has thus been proposed that adiponectin may be a biological link between obesity (especially central obesity) and increased cancer risk. Adiponectin may influence cancer risk through its well-recognized effects on insulin resistance, but it is also plausible that adiponectin acts on tumor cells directly. Several cancer cell types express adiponectin receptors that may mediate the effects of adiponectin on cellular proliferation. Herein, we review recent evidence supporting a role of serum adiponectin concentrations as a novel risk factor and possible diagnostic marker for obesity-related malignancies, including cancers of the breast, endometrium, colon, and prostate. Further studies are needed to fully elucidate the potential role of adiponectin in cancer diagnostics and therapeutics.

[1]  Y. Miyoshi,et al.  Demonstration of adiponectin receptors 1 and 2 mRNA expression in human breast cancer cells. , 2007, Cancer letters.

[2]  C. Mantzoros,et al.  Low adiponectin levels are associated with renal cell carcinoma: A case‐control study , 2007, International journal of cancer.

[3]  C. Mantzoros,et al.  Regulation of adiponectin and its receptors in response to development of diet-induced obesity in mice. , 2007, American journal of physiology. Endocrinology and metabolism.

[4]  C. Mantzoros,et al.  Total and high-molecular-weight adiponectin in breast cancer: in vitro and in vivo studies. , 2007, The Journal of clinical endocrinology and metabolism.

[5]  Limei Liu,et al.  Adiponectin modulates carnitine palmitoyltransferase-1 through AMPK signaling cascade in rat cardiomyocytes , 2007, Regulatory Peptides.

[6]  C. Mantzoros,et al.  Serum Adiponectin Concentrations and Tissue Expression of Adiponectin Receptors Are Reduced in Patients with Prostate Cancer: A Case Control Study , 2007, Cancer Epidemiology Biomarkers & Prevention.

[7]  W. Willett,et al.  Plasma adiponectin concentrations and risk of incident breast cancer. , 2006, The Journal of clinical endocrinology and metabolism.

[8]  C. Friedenreich,et al.  Plasma adiponectin levels and endometrial cancer risk in pre- and postmenopausal women. , 2007, The Journal of clinical endocrinology and metabolism.

[9]  G. Chrousos,et al.  Antiproliferative effect of adiponectin on MCF7 breast cancer cells: a potential hormonal link between obesity and cancer. , 2007, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[10]  A. Xu,et al.  Adiponectin modulates the glycogen synthase kinase-3beta/beta-catenin signaling pathway and attenuates mammary tumorigenesis of MDA-MB-231 cells in nude mice. , 2006, Cancer research.

[11]  H. Randeva,et al.  The regulation of adiponectin receptors in human prostate cancer cell lines. , 2006, Biochemical and biophysical research communications.

[12]  M. J. Yoon,et al.  Adiponectin Increases Fatty Acid Oxidation in Skeletal Muscle Cells by Sequential Activation of AMP-Activated Protein Kinase, p38 Mitogen-Activated Protein Kinase, and Peroxisome Proliferator–Activated Receptor α , 2006, Diabetes.

[13]  C. Mantzoros,et al.  Adiponectin: a link between obesity and cancer , 2006, Expert opinion on investigational drugs.

[14]  I. Thompson,et al.  Obesity, Adipokines, and Prostate Cancer in a Prospective Population-Based Study , 2006, Cancer Epidemiology Biomarkers & Prevention.

[15]  Y. Taketani,et al.  Expression of adiponectin receptors and its possible implication in the human endometrium. , 2006, Endocrinology.

[16]  M. Dieudonné,et al.  Adiponectin mediates antiproliferative and apoptotic responses in human MCF7 breast cancer cells. , 2006, Biochemical and biophysical research communications.

[17]  M. Hou,et al.  Serum adiponectin and leptin levels in Taiwanese breast cancer patients. , 2006, Cancer letters.

[18]  K. Lu,et al.  Association between adiponectin, insulin resistance, and endometrial cancer , 2006, Cancer.

[19]  O. Ogunwobi,et al.  Adiponectin stimulates proliferation and cytokine secretion in colonic epithelial cells , 2006, Regulatory Peptides.

[20]  J. Manson,et al.  Adiponectin Genetic Variability, Plasma Adiponectin, and Cardiovascular Risk in Patients With Type 2 Diabetes , 2006, Diabetes.

[21]  M. Yılmaz,et al.  Association of Plasma Adiponectin Concentrations with Chronic Lymphocytic Leukemia and Myeloproliferative Diseases , 2006, International journal of hematology.

[22]  J. Bub,et al.  Adiponectin as a growth inhibitor in prostate cancer cells. , 2006, Biochemical and biophysical research communications.

[23]  C. Mantzoros,et al.  Adiponectin in relation to childhood myeloblastic leukaemia , 2006, British Journal of Cancer.

[24]  J. Manson,et al.  Adherence to the Mediterranean dietary pattern is positively associated with plasma adiponectin concentrations in diabetic women. , 2006, The American journal of clinical nutrition.

[25]  ShinjiKihara,et al.  Adiponectin Inhibits Endothelial Synthesis of Interleukin-8 , 2005 .

[26]  Takashi Kadowaki,et al.  Combination , 2019, Understanding the Law of Assignment.

[27]  W. Willett,et al.  Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study. , 2005, Journal of the National Cancer Institute.

[28]  B. Yu,et al.  Adiponectin induces growth arrest and apoptosis of MDA-MB-231 breast cancer cell , 2005, Archives of pharmacal research.

[29]  A. Partin,et al.  Association between serum adiponectin, and pathological stage and grade in men undergoing radical prostatectomy. , 2005, The Journal of urology.

[30]  A. Seftel.  Testosterone selectively reduces the high molecular weight form of adiponectin by inhibiting its secretion from adipocytes. , 2005, The Journal of urology.

[31]  L. Campbell,et al.  The metabolism of isoforms of human adiponectin: studies in human subjects and in experimental animals. , 2005, European journal of endocrinology.

[32]  M. Akahane,et al.  Physiological difference between obese (fa/fa) Zucker rats and lean Zucker rats concerning adiponectin. , 2005, Metabolism: clinical and experimental.

[33]  J. Manson,et al.  Circulating adiponectin levels are associated with better glycemic control, more favorable lipid profile, and reduced inflammation in women with type 2 diabetes. , 2005, The Journal of clinical endocrinology and metabolism.

[34]  D. Pipeleers,et al.  Adiponectin-mediated stimulation of AMP-activated protein kinase (AMPK) in pancreatic beta cells. , 2005, Life sciences.

[35]  J. Bub,et al.  Adiponectin activates c-Jun NH2-terminal kinase and inhibits signal transducer and activator of transcription 3. , 2005, Biochemical and biophysical research communications.

[36]  M. Stumvoll,et al.  Adiponectin receptor gene expression in human skeletal muscle cells is not regulated by fibrates and thiazolidinediones , 2005, International Journal of Obesity.

[37]  K. Çağlar,et al.  Prostate cancer and adiponectin. , 2005, Urology.

[38]  W. Hanif,et al.  Serum high molecular weight complex of adiponectin correlates better with glucose tolerance than total serum adiponectin in Indo-Asian males , 2005, Diabetologia.

[39]  A. Xu,et al.  Adiponectin Inhibits Cell Proliferation by Interacting with Several Growth Factors in an Oligomerization-dependent Manner* , 2005, Journal of Biological Chemistry.

[40]  T. Kadowaki,et al.  Adiponectin and adiponectin receptors. , 2005, Endocrine reviews.

[41]  K. Inukai,et al.  Regulation of adiponectin receptor gene expression in diabetic mice. , 2005, American journal of physiology. Endocrinology and metabolism.

[42]  Lu Qi,et al.  Dietary glycemic index, glycemic load, cereal fiber, and plasma adiponectin concentration in diabetic men. , 2005, Diabetes care.

[43]  Nader Rifai,et al.  Association between dietary factors and plasma adiponectin concentrations in men. , 2005, The American journal of clinical nutrition.

[44]  T. Kadowaki,et al.  Generation of globular fragment of adiponectin by leukocyte elastase secreted by monocytic cell line THP-1. , 2005, Endocrinology.

[45]  N. Ruderman,et al.  AMPK, the metabolic syndrome and cancer. , 2005, Trends in pharmacological sciences.

[46]  E. Rimm,et al.  Adiponectin and future coronary heart disease events among men with type 2 diabetes. , 2005, Diabetes.

[47]  H. Nagawa,et al.  Plasma adiponectin and gastric cancer. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

[48]  K. Herbst,et al.  Testosterone administration suppresses adiponectin levels in men. , 2005, Journal of andrology.

[49]  土田 敦之.  Insulin/Foxo1 pathway regulates expression levels of adiponectin receptors and adiponectin sensitivity , 2005 .

[50]  S. Kihara,et al.  Adiponectin-mediated modulation of hypertrophic signals in the heart , 2004, Nature Medicine.

[51]  H. Tilg,et al.  Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes. , 2004, Biochemical and biophysical research communications.

[52]  E. Calle,et al.  Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms , 2004, Nature Reviews Cancer.

[53]  H. Lodish,et al.  A family of Acrp30/adiponectin structural and functional paralogs. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[54]  H. Lodish,et al.  T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[55]  E. Rimm,et al.  Relationship between adiponectin and glycemic control, blood lipids, and inflammatory markers in men with type 2 diabetes. , 2004, Diabetes care.

[56]  J. Flier,et al.  Adipose Tissue as an Endocrine Organ , 2014 .

[57]  B. Goldstein,et al.  Adiponectin: A novel adipokine linking adipocytes and vascular function. , 2004, The Journal of clinical endocrinology and metabolism.

[58]  S. Kihara,et al.  Adiponectin Specifically Increased Tissue Inhibitor of Metalloproteinase-1 Through Interleukin-10 Expression in Human Macrophages , 2004, Circulation.

[59]  R. Scolyer,et al.  The significance of the Wnt pathway in the pathology of human cancers. , 2004, Pathology.

[60]  John A Wagner,et al.  Complex Distribution, Not Absolute Amount of Adiponectin, Correlates with Thiazolidinedione-mediated Improvement in Insulin Sensitivity* , 2004, Journal of Biological Chemistry.

[61]  A. Garg.  Acquired and inherited lipodystrophies. , 2004, The New England journal of medicine.

[62]  C. Mantzoros,et al.  Adiponectin and breast cancer risk. , 2004, The Journal of clinical endocrinology and metabolism.

[63]  C. Mantzoros,et al.  Circulating adiponectin and endometrial cancer risk. , 2004, The Journal of clinical endocrinology and metabolism.

[64]  P. Arner,et al.  Adipose tissue adiponectin production and adiponectin serum concentration in human obesity and insulin resistance. , 2004, The Journal of clinical endocrinology and metabolism.

[65]  S. Kihara,et al.  Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[66]  R. Nagai,et al.  Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells: a new insight into adipocytokine-endothelial cell interactions. , 2004, Biochemical and biophysical research communications.

[67]  C. Mantzoros,et al.  Energy homeostasis, obesity and eating disorders: recent advances in endocrinology. , 2004, The Journal of nutrition.

[68]  S. Kihara,et al.  Adiponectin Stimulates Angiogenesis by Promoting Cross-talk between AMP-activated Protein Kinase and Akt Signaling in Endothelial Cells* , 2004, Journal of Biological Chemistry.

[69]  D. Eizirik,et al.  Expression of adiponectin receptors in pancreatic beta cells. , 2003, Biochemical and biophysical research communications.

[70]  H. Lodish,et al.  Role of Disulfide Bonds in Acrp30/Adiponectin Structure and Signaling Specificity , 2003, Journal of Biological Chemistry.

[71]  S. Kihara,et al.  Association of serum adiponectin levels with breast cancer risk. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[72]  Hui Chen,et al.  Adiponectin Stimulates Production of Nitric Oxide in Vascular Endothelial Cells* , 2003, Journal of Biological Chemistry.

[73]  J. Chan,et al.  Serum adiponectin levels are inversely associated with overall and central fat distribution but are not directly regulated by acute fasting or leptin administration in humans: cross-sectional and interventional studies. , 2003, The Journal of clinical endocrinology and metabolism.

[74]  Philippe Froguel,et al.  Cloning of adiponectin receptors that mediate antidiabetic metabolic effects , 2003, Nature.

[75]  P. Scherer,et al.  Adiponectin: Systemic contributor to insulin sensitivity , 2003, Current diabetes reports.

[76]  H. Motoshima,et al.  Involvement of AMP-activated protein kinase in glucose uptake stimulated by the globular domain of adiponectin in primary rat adipocytes. , 2003, Diabetes.

[77]  M. Cnop,et al.  Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex , 2003, Diabetologia.

[78]  J. Engel,et al.  Structure-Function Studies of the Adipocyte-secreted Hormone Acrp30/Adiponectin , 2003, The Journal of Biological Chemistry.

[79]  C. Mantzoros,et al.  Plasma adiponectin concentrations in relation to endometrial cancer: a case-control study in Greece. , 2003, The Journal of clinical endocrinology and metabolism.

[80]  Pedro Iglesias,et al.  The role of the novel adipocyte-derived hormone adiponectin in human disease. , 2003, European journal of endocrinology.

[81]  H. Lodish,et al.  Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: Acetyl–CoA carboxylase inhibition and AMP-activated protein kinase activation , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[82]  S. Kihara,et al.  Adiponectin Reduces Atherosclerosis in Apolipoprotein E-Deficient Mice , 2002, Circulation.

[83]  S. Uchida,et al.  Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase , 2002, Nature Medicine.

[84]  T. Funahashi,et al.  Plasma adiponectin concentrations in children: relationships with obesity and insulinemia. , 2002, The Journal of clinical endocrinology and metabolism.

[85]  M. Matsuda,et al.  Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. , 2002, Diabetes.

[86]  H. Lodish,et al.  Oligomerization State-dependent Activation of NF-κB Signaling Pathway by Adipocyte Complement-related Protein of 30 kDa (Acrp30)* , 2002, The Journal of Biological Chemistry.

[87]  T. Saruta,et al.  Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population. , 2002, Clinical science.

[88]  Philippe Froguel,et al.  Disruption of Adiponectin Causes Insulin Resistance and Neointimal Formation* , 2002, The Journal of Biological Chemistry.

[89]  S. Kihara,et al.  Adipocyte-Derived Plasma Protein Adiponectin Acts as a Platelet-Derived Growth Factor-BB–Binding Protein and Regulates Growth Factor–Induced Common Postreceptor Signal in Vascular Smooth Muscle Cell , 2002, Circulation.

[90]  C. Bogardus,et al.  Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans. , 2002, Diabetes.

[91]  Xi He,et al.  Control of β-Catenin Phosphorylation/Degradation by a Dual-Kinase Mechanism , 2002, Cell.

[92]  P. Scherer,et al.  ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism , 2002, Trends in Endocrinology & Metabolism.

[93]  Xi He,et al.  Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism. , 2002, Cell.

[94]  L. Rossetti,et al.  Endogenous glucose production is inhibited by the adipose-derived protein Acrp30. , 2001, The Journal of clinical investigation.

[95]  P. Scherer,et al.  The adipocyte-secreted protein Acrp30 enhances hepatic insulin action , 2001, Nature Medicine.

[96]  T. Tai,et al.  Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. , 2001, The Journal of clinical endocrinology and metabolism.

[97]  T. Funahashi,et al.  The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2001 by The Endocrine Society Hypoadiponectinemia in Obesity and Type 2 Diabetes: Close Association with Insulin Resistance , 2022 .

[98]  H. Lodish,et al.  Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[99]  大内 乗有.  Novel modulator for endothelial adhesion molecules : Adipocyte-derived plasma protein adiponectin , 2001 .

[100]  J. Weber,et al.  Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[101]  S. Kihara,et al.  Adiponectin, an Adipocyte-Derived Plasma Protein, Inhibits Endothelial NF-&kgr;B Signaling Through a cAMP-Dependent Pathway , 2000, Circulation.

[102]  S. Kihara,et al.  Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. , 2000, Blood.

[103]  S. Kihara,et al.  Genomic structure and mutations in adipose-specific gene, adiponectin , 2000, International Journal of Obesity.

[104]  T Nakamura,et al.  Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[105]  H. Wu,et al.  Suppression of angiogenesis and tumor growth by the inhibitor K1-5 generated by plasmin-mediated proteolysis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[106]  S. Kihara,et al.  PARADOXICAL DECREASE OF OBTAIN A BETTER UNDERSTANDING OF ADIPONECTIN'S ROLE IN THE ADIPOSE-SPECIFIC PROTEIN, ADIPONECTIN IN OBESITY , 1999 .

[107]  Y. Nakano,et al.  Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma. , 1996, Journal of biochemistry.

[108]  B. Spiegelman,et al.  AdipoQ Is a Novel Adipose-specific Gene Dysregulated in Obesity (*) , 1996, The Journal of Biological Chemistry.

[109]  T. Funahashi,et al.  cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). , 1996, Biochemical and biophysical research communications.

[110]  Philipp E. Scherer,et al.  A Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes (*) , 1995, The Journal of Biological Chemistry.

[111]  J. Folkman.  What is the evidence that tumors are angiogenesis dependent? , 1990, Journal of the National Cancer Institute.